Financial Data and Key Metrics Changes - The company expects consolidated net sales growth of 4% at the midpoint for fiscal 2026, reflecting confidence in its strategy and execution capabilities [8][10] - Inventory increased by $35 million or 48% to $107 million at the end of fiscal 2025, primarily driven by growth initiatives at Rise Wellness and Hiya [11] Business Line Data and Key Metrics Changes - Rise Wellness and Hiya are identified as key drivers of sales growth, with Rise expected to operate at approximately break-even in fiscal 2026 while supporting future growth [12] - The company is focusing on expanding its omni-channel reach and enhancing product innovation to drive sales momentum [8][9] Market Data and Key Metrics Changes - The company is diversifying its distribution channels to access a larger global base of health-conscious consumers, particularly through retail partnerships with major retailers like Target and Costco [24][33] - The core nutritional business is experiencing year-over-year sales declines but shows signs of stabilization [14] Company Strategy and Development Direction - The company aims to transition from a legacy Direct Selling business to a modern, science-driven nutritional products company [7] - Key strategic priorities include strengthening global brand positioning, enhancing customer experience, and improving operational efficiencies [6][8] Management's Comments on Operating Environment and Future Outlook - Management acknowledges the evolving external environment and emphasizes the need for speed, focus, and precision in execution [6] - The company is committed to long-term strategic execution rather than short-term optimization, aiming to strengthen its foundation for future growth [8][14] Other Important Information - The effective income tax rate for fiscal 2026 is expected to range between 55% and 60%, influenced by geographic misalignment between revenue and costs [12] - The company plans to leverage technology modernization to improve customer experience and operational efficiencies [10][43] Q&A Session Summary Question: Can you walk us through the guidance for revenue and EPS? - Management discussed the potential for achieving the top end of guidance through improved macro conditions and specific brand performance [16][20] Question: What is the expected seasonality of the business? - Management indicated that seasonality is influenced by events like the Lunar New Year, with Q1 typically stronger due to promotional activities [33][35] Question: How much did the cost realignment impact headcount and what are the implications for gross margins? - Approximately 10% of the workforce was impacted, resulting in about $10 million in savings, with expectations for gross margins to be affected by the mix of different businesses [39][41] Question: What are the company's thoughts on integrating technology into consumer health management? - Management expressed interest in utilizing technology to personalize nutrition and enhance consumer engagement, emphasizing the importance of staying relevant in the market [50][52]
USANA Health Sciences(USNA) - 2025 Q4 - Earnings Call Transcript